William D. Humphries

Insider Reports History

Location
Horsham, PA
Signature
/s/ Matthew Rothman, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by William D. Humphries:

Company Role Class Num Shares Value Price $ Report Date Ownership
Clearside Biomedical, Inc. Director Common Stock 51,040 $64,821 $1.27 22 Sep 2023 Direct
STRATA Skin Sciences, Inc. Director SSKN Common Stock 109,724 $51,570 $0.4700 05 Jul 2023 Direct
Aclaris Therapeutics, Inc. Director Common Stock 33,525 $51,293 $1.53 06 Jun 2025 Direct
Aclaris Therapeutics, Inc. Director Restricted Stock Units 0 $4,937 $1.03 06 Jun 2025 Direct
Clearside Biomedical, Inc. Director Stock Option (right to buy) 45,000 20 Jun 2024 Direct
Aclaris Therapeutics, Inc. Director Stock Option (Right to Buy) 42,350 05 Jun 2025 Direct
PhaseBio Pharmaceuticals Inc Director Non-employee Director Stock Option (right to buy) 11,842 19 May 2022 Direct
PhaseBio Pharmaceuticals Inc Director Common Stock 2,538 19 May 2023 Direct
PhaseBio Pharmaceuticals Inc Director Restricted Stock Units 0 19 May 2023 Direct

Insider Reports Filed by William D. Humphries

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ACRS Aclaris Therapeutics, Inc. 05 Jun 2025 4 $0 4 Director 09 Jun 2025, 16:20
CLSD Clearside Biomedical, Inc. 20 Jun 2024 1 $0 4 Director 21 Jun 2024, 16:15
ACRS Aclaris Therapeutics, Inc. 06 Jun 2024 2 $0 4 Director 10 Jun 2024, 16:15
ACRS Aclaris Therapeutics, Inc. 01 Jun 2024 2 $0 4 Director 04 Jun 2024, 16:30
CLSD Clearside Biomedical, Inc. 22 Sep 2023 2 +$9,091 4 Director 22 Sep 2023, 17:35
SSKN STRATA Skin Sciences, Inc. 05 Jul 2023 1 +$37,500 4 Director 07 Jul 2023, 16:06
CLSD Clearside Biomedical, Inc. 22 Jun 2023 1 $0 4 Director 23 Jun 2023, 16:38
ACRS Aclaris Therapeutics, Inc. 01 Jun 2023 4 $0 4 Director 05 Jun 2023, 17:12
/report/000116924523000031-humphries-william-d-2023-05-19 PhaseBio Pharmaceuticals Inc 19 May 2023 2 $0 4 Director 19 May 2023, 16:18
CLSD Clearside Biomedical, Inc. 22 Jun 2022 1 $0 4 Director 24 Jun 2022, 16:22
ACRS Aclaris Therapeutics, Inc. 02 Jun 2022 4 $0 4 Director 06 Jun 2022, 17:18
/report/000116924522000081-humphries-william-d-2022-05-19-restatement PhaseBio Pharmaceuticals Inc 19 May 2022 2 $0 4/A Director 10 Jun 2022, 16:20
SSKN STRATA Skin Sciences, Inc. 25 Mar 2022 1 +$29,385 4 Director 28 Mar 2022, 17:03
SSKN STRATA Skin Sciences, Inc. 24 Mar 2022 1 +$23,387 4 Director 24 Mar 2022, 20:32
CLSD Clearside Biomedical, Inc. 10 Jan 2022 2 +$3,409 4 Director 11 Jan 2022, 15:45
/report/000116924521000097-humphries-william-d-2021-09-14 PhaseBio Pharmaceuticals Inc 14 Sep 2021 1 $0 4 Director 15 Sep 2021, 08:15
/report/000116924521000096-humphries-william-d-2021-09-14 PhaseBio Pharmaceuticals Inc 14 Sep 2021 0 $0 3 Director 15 Sep 2021, 08:14
SSKN STRATA Skin Sciences, Inc. 20 Aug 2021 1 $0 4 Director 23 Aug 2021, 16:44
SSKN STRATA Skin Sciences, Inc. 20 Jul 2021 2 $0 4 Director 21 Jul 2021, 17:28
CLSD Clearside Biomedical, Inc. 10 Jun 2021 1 $0 4 Director 11 Jun 2021, 17:35
ACRS Aclaris Therapeutics, Inc. 03 Jun 2021 2 $0 4 Director 04 Jun 2021, 19:57